2021 CMSC Annual Meeting

Tag: 7539DMT09Poster-Disease-modifying TherapyAlexander J. Keenan

Poster-Disease-modifying Therapy

Assessment of Composite Disability Accumulation of Ponesimod Relative to Teriflunomide in the Optimum Phase 3 Study

Background: In relapsing forms of Multiple Sclerosis, disability progression has been shown to be independent of relapses. A new concept in...

Read More